• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconAllergan

Allergan

Page 2 of 6
A silver foil strip with white medicine tablets, displayed
HealthA Promising Antibiotic for a Deadly Infection Is Sending Paratek Pharma’s Stock Soaring
By Sy MukherjeeApril 4, 2017
Researchers bring gene editing to patients with deadly diseases
HealthAllergan Just Got Access to Groundbreaking Gene-Editing Treatments for Eye Diseases
By Sy MukherjeeMarch 15, 2017
CNBC Events
HealthA Pharma CEO Says What Few Will
By Clifton LeafFebruary 27, 2017
HealthWhat Allergan’s CEO Thinks About Donald Trump and Drug Prices
By Sy MukherjeeFebruary 26, 2017
CNBC Events
HealthAllergan’s CEO Has Struck an Insane Number of Biotech Deals
By Sy MukherjeeDecember 21, 2016
Allergan Plc Offices Ahead Of Earnings Figure
HealthAllergan Buys Regenerative Medicine Unit LifeCell for $2.9 Billion
By ReutersDecember 20, 2016
FRANCE-POLITICS-INDUSTRY
HealthA Second Pharma Giant Just Promised to Ditch Crazy Drug Price Hikes
By Sy MukherjeeDecember 6, 2016
Dr. Ulf M. Schneider (li.), Rice Powell.
HealthNestlé Just Snatched Up Another Big Biopharma Exec in Its Health Care Push
By Sy MukherjeeOctober 11, 2016
HealthWhy Allergan Is Willing to Pay So Much Money for This Biotech
By Sy MukherjeeSeptember 20, 2016
CNBC Events
HealthAllergan’s CEO Just Pledged a ‘Social Contract’ With Patients on Drug Prices
By Sy MukherjeeSeptember 6, 2016
The New York Times 2015 DealBook Conference
FinanceCarl Icahn Increases Allergan Stake
By ReutersAugust 16, 2016
90306508
FinanceFailed Pfizer-Allergan Merger Had Hedge Funds Scrambling in Q2
By Reuters and Aaron TaskAugust 15, 2016
Pfizer Inc. Headquarters As They Agree To Combine With Allergan Plc In $160 Billion Deal
FinanceBig Business Groups Just Sued the Government for Blocking the Pfizer-Allergan Merger
By Jen WiecznerAugust 4, 2016
Pfizer Inc. Headquarters As They Agree To Combine With Allergan Plc In $160 Billion Deal
FinancePfizer Breakup May Depend on Trump or Clinton Winning the Election
By Jen WiecznerAugust 2, 2016
George Scangos, CEO of Biogen Inc. speaks during Reuters Health Summit in New York
HealthBiogen Shares Are Spiking On Rumors of a Mega-Deal With Its Rivals
By Sy MukherjeeAugust 2, 2016
1
  • 1
  • 2
  • 3
  • 4
  • 5
6
Most Popular
Economy
Elon Musk warns the U.S. is '1,000% going to go bankrupt' unless AI and robotics save the economy from crushing debtAn image of a popular article
By Jason MaFebruary 7, 2026
Success
Even with $850 billion to his name, Elon Musk admits ‘money can’t buy happiness.’ But billionaire Mark Cuban says it’s not so simpleAn image of a popular article
By Preston ForeFebruary 6, 2026
Success
Gen Z Patriots quarterback Drake Maye still drives a 2015 pickup truck even after it broke down on the highway—despite his $37 million contractAn image of a popular article
By Sasha RogelbergFebruary 7, 2026
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.